Maria Gobbi

Maria Gobbi

Director Director DIN 07005222
DIN 07005222 First appointment Nov 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2014
Shareholding value Locked Premium profile

About Maria Gobbi

Data last updated:

Maria Gobbi has 11 years in corporate governance. Formerly with 1 company, such as Fresenius Kabi Oncology Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07005222
Primary Designation Director
First Appointment 13 Nov 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Fresenius Kabi Oncology Limited U24231DL2003PLC119441
Director13 Nov 20142003Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fresenius Kabi Oncology Limited
Premium access

Shareholding and investment profile for Maria Gobbi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maria Gobbi

Maria Gobbi has 11 years in corporate governance. Formerly with 1 company, such as Fresenius Kabi Oncology Limited. Engaged in General Business. Contributes to corporate operations.

Maria Gobbi is associated with 0 companies as a director.

Maria Gobbi has expertise in General Business.

Maria Gobbi has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available